Related Experiment Video

Updated: Jun 17, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

More than an accessory: implications of type III transforming growth factor-beta receptor loss in prostate cancer

Seun Ajiboye1, Tristan M Sissung, Nima Sharifi

  • 1Molecular Pharmacology Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

BJU International
|January 14, 2010
PubMed

Insights

Loss of the type III transforming growth factor-beta receptor (TGFbetaR3) promotes prostate cancer progression and metastasis. Understanding TGFbetaR3's role is crucial for developing targeted cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The type III transforming growth factor-beta receptor (TGFbetaR3), also known as betaglycan, acts as a tumor suppressor.
  • TGFbetaR3 is frequently lost in various cancers, particularly prostate cancer.
  • Loss of TGFbetaR3 is linked to the shift in TGFbeta pathway activity from tumor suppression to tumor promotion.

Purpose of the Study:

  • To review the normal function of TGFbetaR3 in the TGFbeta pathway.
  • To elucidate the relationship between TGFbetaR3 loss and prostate tumor progression.
  • To discuss the therapeutic implications of TGFbetaR3 loss in prostate cancer treatment.

Main Methods:

  • Literature review of studies on TGFbetaR3 function and its role in prostate cancer.
  • Analysis of the molecular mechanisms underlying TGFbetaR3's tumor-suppressive and tumor-promoting activities.
  • Examination of the impact of TGFbetaR3 loss on cellular responses and growth factor pathways.

Main Results:

  • TGFbetaR3 functions as a critical accessory protein in the TGFbeta signaling pathway.
  • Loss of TGFbetaR3 is a key event in the transition of prostate cancer from early-stage suppression to metastatic promotion.
  • TGFbetaR3 loss dysregulates cellular responses to hormones and growth factors, impacting angiogenesis.

Conclusions:

  • TGFbetaR3 plays a vital role in maintaining the tumor-suppressive functions of the TGFbeta pathway.
  • The loss of TGFbetaR3 is a significant driver of prostate cancer progression and metastasis.
  • Targeting TGFbetaR3 or its pathway presents a potential therapeutic strategy for prostate cancer.

More Related Videos

Spheroid Assay to Measure TGF-β-induced Invasion09:18

Spheroid Assay to Measure TGF-β-induced Invasion

Published on: November 16, 2011

An Orthotopic Murine Model of Human Prostate Cancer Metastasis06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...